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Abstract
Background: Little is known about the management of methicillin-resistant Staphylococcus aureus (MRSA) carriers
in the German outpatient sector and about the impact of MRSA on their daily life. Reimbursement for MRSA related
costs in the German outpatient sector is available since 2012, but its impact has not been studied yet. The aim of
the study was to analyze the outpatient management of MRSA carriers from both, physicians’ and MRSA carriers’
perspective.
Methods: Paper-based questionnaires were mailed to physicians providing outpatient care and to MRSA carriers in
2013. MRSA carriers were recruited among patients tested positive for MRSA during a hospital stay in 2012. General
practitioners, specialists for internal medicine, urologists, and dermatologists working in the outpatient catchment
areas of the hospitals were contacted.
Results: Out of 910 MRSA carriers 16.5 % completed the questionnaires; among 851 physicians 9.5 % participated.
27.3 % of the responding MRSA carriers stated that no healthcare professional had ever talked to them about
MRSA. 17.4 % reported self-stigmatization in terms of restricting social contacts; 47.3 % remembered decolonization
and 33.3 % reported that their MRSA status was checked after discharge. Physicians displayed heterogeneous
attitude and activity towards MRSA (number of applied decolonization and MRSA screenings). A minority (15.2 %)
were satisfied with the reimbursement of costs, 35.9 % reported full agreement with the general recommendations
for the handling of MRSA carriers.
Conclusions: MRSA carriers appear not well informed; (self-) stigmatization is occurring and should be tackled.
Greater awareness of MRSA as a problem in the outpatient sector could lead to a better handling of MRSA carriers.
Keywords: MRSA, Stigmatization, Outpatient sector, Decolonization
Background
Methicillin-resistant Staphylococcus aureus (MRSA) has a
prevalence of around 2.2 % in newly admitted patients to
German hospitals [1] and can be detected in 18–20 % of in-
patients’ derived Staphylococcus aureus isolates [2]. To di-
minish the overall load of MRSA, a bundle of measurements
is recommended both, on the hospital level (e.g., isolation)
and on the individual level (e.g., decolonization therapy) [3].
While the spread of MRSA is especially problematic in the
inpatient sector, transmissions can be initiated by MRSA car-
riers readmitted to the hospital. In order to interrupt the
MRSA transmission, not only measures in the hospital but
also follow-up and decolonization of patients in the out-
patient sector is necessary. Meyer et al. [4] reported that
decolonization therapy can be applied successfully in the
outpatient sector and pointed out that a close cooperation
between outpatient and inpatient sector is necessary. How-
ever, a follow-up system for MRSA carriers (or carriers of
other multiresistant pathogens) across sectoral borders (in-
patient vs. outpatient) is missing in Germany, and we could
not find any international studies concerning this subject.
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The German College of General Practitioners and Family
Physicians (DEGAM) had published guidelines for the diag-
nosis and therapy of MRSA in the outpatient sector in Sep-
tember 2013 (three months before the survey). These
recommendations are in accordance with the ones of the
KBV (National Association of Statutory Health Insurance
Physicians) published earlier. Both recommend MRSA
screening for patients with an increased risk of being
MRSA-positive, as well as three control swabs 48 h, 3–6
months and 12 months after application of a decolonization
therapy. This treatment is recommended for all MRSA car-
riers; however, in case of factors that might decrease the
success such as chronic wounds, the physician can opt out.
The guidelines recommend up to two decolonization ther-
apies before consulting a specialist, e.g., a MRSA network.
The treatment should comprise a bundle of measures
(nasal ointment, mouthwashes, and daily disinfection of
hair and skin for 5 days). Accompanying measures should
include daily change of clothes, bedding and towels, and
disinfection or daily change of hygiene utensils [5].
In order to improve treatment of MRSA in the out-
patient sector, reimbursement of the costs for MRSA
screening, control swabs, and decolonization therapy was
introduced in April 2012 by the Federal Joint Committee
(“Gemeinsamer Bundesausschuß”), and the reimburse-
ment is now paid by statutory health insurances. It is
noteworthy, that only the costs for nasal ointment (mupir-
ocin) are covered by the statutory health insurances. The
impact of this reimbursement has not been studied yet.
In addition, risk perceptions regarding MRSA are
likely to cause stigmatization of MRSA carriers, as was
described for the UK [6] and for Sweden [7]. Up to now,
nothing is known about the perception of stigmatization
due to MRSA in the daily life of MRSA carriers after dis-
charge from hospital in Germany [8]. Greiner [9] dem-
onstrated a considerable loss of quality of life for
patients with MRSA infection, but no data are available
about the quality of life of MRSA carriers without symp-
toms of MRSA infection.
Therefore, our study aimed at assessing knowledge, at-
titude, and practice related to MRSA among MRSA car-
riers and among physicians in outpatient care in two
regions of Germany after the introduction of an add-
itional reimbursement for MRSA specific care. In
addition, we studied the perceived stigmatization and
quality of life in MRSA carriers. Beside this quantitative
approach, we initiated focus groups with MRSA carriers
from the same study population [10].
Methods
Study population
MRSA carriers were recruited in collaboration with two
tertiary care hospitals in Lower Saxony and North
Rhine-Westphalia in November and December 2013.
Inclusion criterion was a positive MRSA test during a hos-
pital stay in 2012, that is 12 to 24 months before initiation
of the study. For simplification, we call these patients
“MRSA carriers”, regardless of their current MRSA status
and if they initially had a MRSA colonization or a MRSA
infection. The questionnaires were mailed to their home
addresses from the hospitals. The questionnaire for physi-
cians was sent to all general practitioners (GPs), specialists
for internal medicine, dermatologists, and urologists in
the catchment area of the two hospitals between October
and November 2013. We focused on these specialities in
order to query physicians who presumably frequently deal
with MRSA positive patients.
Ethics Statement
All questionnaires were filled in anonymously by the partic-
ipants. The study was approved by the Ethics committees
of Hannover Medical School (No. 1893–2013) and the
University Witten/Herdecke (No. 112/2013).
Questionnaires
Physicians in outpatient care
We developed a questionnaire assessing relevance of
MRSA in their practices (11-point scale), knowledge of
the refunding possibilities for MRSA screening and
treatment, and satisfaction with financial reimbursement
for MRSA specific care. Knowledge of MRSA was evalu-
ated by a cumulative score; for further analysis, we di-
chotomized this knowledge score (lower group 0–3
points, higher group 4–7 points). To assess their activity
regarding MRSA, we asked how many screening tests
and decolonization therapies they applied and if they are
members of a MRSA network which is a regional quality
management measure for training and discussions on
MRSA. The questionnaire was piloted for clarity and
comprehension with three GPs and one specialist in in-
ternal medicine working in the outpatient sector. The
translated version of the questionnaire for physicians is
available as Additional file 1.
MRSA carriers
Analogously, we developed a questionnaire for MRSA car-
riers, including questions on MRSA history, general state of
health, perceived stigmatization, and socio-demographic
data. As among physicians, knowledge of MRSA was
assessed by a cumulative score based on 7 items and di-
chotomized for further analysis (lower group 0–3 points,
higher group 4–7 points, one point for every correct an-
swer). Two questions focused on the patients’ attitudes
towards MRSA, namely the importance respondents attrib-
uted personally to MRSA, and if they were scared of
MRSA, with answer categories on a 5-point Likert scale.
We reclassified the responses into two categories (high:“-
yes a lot” and “yes, some” vs. low:“neutral”, “rather not”
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and “not”). Furthermore, we included questions on
decolonization and control swabs as well as eight ques-
tions about perceived constraints in daily life and per-
ceived stigmatization. The translated version of the
questionnaire for MRSA carriers is available as Additional
file 2. We added one question on the self-rated health sta-
tus which was previously used as a single item in several
studies, e.g., in the 1998 German Federal Health Survey
[11]. The questionnaire was piloted with four healthy
adults for comprehension.
Statistical analysis
Differences between groups were tested using the chi-
squared test for categorical variables and the Wilcoxon
rank sum test for continuous variables; additionally the
odds ratio with 95 % confidence intervals is indicated for
the univariable analysis. For explorative multivariable ana-
lysis of MRSA related knowledge, we used the dichoto-
mized knowledge score as outcome variable for both,
MRSA carriers and physicians and applied logistic regres-
sion. Variables with p < 0.25 in the univariable analysis as
well as age and sex were included in an automatic forward
selection model building procedure (using as cutoff p = 0.2
for inclusion of variables and p = 0.05 for exclusion, based
on the Wald-Test). The Hosmer–Lemeshow test was used
to test the goodness of fit of the logistic models. The ana-
lysis was carried out using Stata 12 (StataCorp, College
Town, US).
Results
Physicians in the outpatient sector
The response proportion to our questionnaire for physi-
cians was 9.5 % (80/851), 27.8 % of them being female
and 38.0 % being GPs (Table 1).
Only 57.0 % of the physicians were able to correctly
define a patient being at risk for MRSA according to the
definition issued by the ‘National Association of Statu-
tory Health Insurance Physicians’, 51.9 % knew at which
time points control swabs are recommended and 14.0 %
answered all questions about the reimbursement cor-
rectly. Respondents achieved a median of four know-
ledge points out of seven possible. In the multivariable
analysis regarding factors associated with knowledge re-
lated to MRSA, only the variable "relevance" was se-
lected in the model, physicians attributing higher
relevance to MRSA answered more questions correctly
(odds ratio (OR) 1.4 per one point increase, 95 % confi-
dence interval (95 % CI) 1.1 to 1.7, p = 0.002) (Table 2).
Those displaying more activity towards MRSA showed
better knowledge in the univariable analysis. However,
this was not significant in the multivariable model.
Nearly half of the physicians (45.6 %) stated that “Suf-
ficient information about MRSA is available”. One third
(35.9 %) agreed fully with the general recommendations
about handling of MRSA carriers and another 46.2 %
agreed with them “in part”.
According to our respondents, MRSA findings are not
always reported in the discharge documents: 59.0 %
answered the findings were “often” or “very often” re-
ported, 28.2 % “sometimes”, and 12.8 % answered “sel-
dom” or “never”. A notification of a MRSA finding by
telephone was even less common: 5.2 % answered
“often”, 10.4 % “sometimes”, 84.4 % “seldom” or “never”.
Importance attributed to MRSA by the physicians was
fairly heterogeneous: 22.1 % attributted low importance
(0–2 points/11), and 32.5 % attributed high importance
(9–10/11).
Physicians reported that they screened 2 patients (me-
dian) for MRSA in the last 12 months. Furthermore,
they have initiated a median of 2 decolonization therap-
ies ever (Table 1); nearly one third of them (27.9 %) has
never applied a decolonization therapy to a patient while
22.8 % have applied it 10 times or more. Fifty–eight per-
cent of the responding physicians were aware of the
refunding possibilities and satisfaction with the amount
of refunding was distributed as follows: no participant
was “very satisfied”, 15.2 % were “satisfied”, 30.4 % were
“not satisfied”, 54.4 % answered “I don’t know”or did not
answer this question.
Table 1 Characteristics of responding physicians
N (%a)
Total 79 (100 %)
Age, n = 75
Median (IQR) in years 52 (46–58)
Sex, n = 74
Female 22 (27.8 %)
Years of professional experience
in ambulant health care
Median (IQR) in years, n = 74 13.5 (3–34)
Estimated number of MRSA positive
patients in the last 12 months
Median (IQR), n = 77 5 (3–10)
Number of screened patients in the last 12 months
Median (IQR), n = 78 2 (0–6)
Number of decolonized patients ever
Median (IQR), n = 79 2 (0–7)
Discipline, n = 75
General practitioner 30 (38.0 %)
Internal medicine 30 (38.0 %)
Dermatologist 4 (5.1 %)
Urologist 8 (10.1 %)
Other 3 (3.8 %)
IQR interquartile range
a Calculation of proportions includes missing values in the denominator
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MRSA carriers
Based on hospital records, 2250 MRSA carriers were eli-
gible for our study. Of these, we excluded 1089 because
their death was known or assumed by the hospital, and
251 letters were undeliverable. Of the remaining 910
MRSA carriers, 16.5 % (150) sent back a completed
questionnaire (Additional file 3: Figure S1). MRSA car-
riers appeared as a frail study population with a median
age of 71.5 years; 33.3 % reported to have been assigned
a formal long-term care level for purposes of German
health insurance, which corresponds to a considerable
and long-term need of nursing care (Table 3).
To seven knowledge questions, MRSA carriers gave a
median of three correct answers; a majority (64.0 %) an-
swered “don’t know” to at least one question (Fig. 1). In
the multivariable analysis, those participants who had
Table 2 Variables associated with physicians’ knowledge related to MRSA










n (%)a n (%)a
36 (45.6 %) 43 (54.4 %)
Age 0.701 0.8 (0.5–1.4) per
ten years increase
Median (IQR) 52 (46–59) 52 (45–57)
Sex 0.090
Female 13 (39.4 %) 9 (21.4 %) 0.4 (0.1–1.1)
Male 20 (60.6 %) 33 (78.6 %) 1
Professional experience in years 0.909 0.9 (0.6–1.5) per
10 years increase
Median (IQR) 13 (8–24) 14.5 (8–22)
Discipline 0.163
General practitioner 24 (72.7 %) 24 (57.1 %) 1
Other specialist 9 (27.3 %) 18 (42.9 %) 2 (0.7–5.3)
Member of a MRSA-Network 0.135
Yes 2 (5.6 %) 7 (16.3 %) 3.3 (0.6–17.0)
No 34 (94.4 %) 36 (83.7 %) 1
MRSA–certificate 0.005
Yes 8 (22.2 %) 23 (53.5 %) 4.0 (1.5–10.8)
No 28 (77.8 %) 20 (46.5 %) 1
Subjectiv relevance for physician’s work 0.001 1.3 (1.1–1.6) per one
point increase
1.4 (1.1–1.7) per one
point increase
0.002
Median (IQR) 3.5 (1.5;7) 7 (5;8)
Number of MRSA carriers last 12 months 0.030 1.7 (0.9–3.3) per
increase of 10
Median (IQR) 5 (1.5;7) 6 (4;10)
Number of screenings in the last
12 months
0.019 1.1 (0.8–1.6) per
increase of 10
Median (IQR) 2 (0;4) 3 (1;10)
Number of decolonizations 0.0625 1.4 (0.8–2.5) per 10
increase
Median (IQR) 2 (0;4.5) 4 (1;10)
Satisfaction with refunding 0.008
Content 1 (3.9 %) 11 (26.2 %) 1
Discontent 7 (26.9 %) 17 (40.5 %) 0.2 (0.0–2.0)
Don’t know 18 (69.2 %) 14 (33.3 %) 0.1 (0.0–0.6)
a Differences to total N due to missing values
b Logistic regression with forward selection of variables; mutually adjusted for all variables with reported ORs in the table
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sought additional information through internet (OR 5.1;
95 % CI 1.8 to 14.0, p = 0.002) or newspapers (OR 5.4;
95 % CI 1.6 to 17.5, p = 0.005) showed significantly more
knowledge about MRSA. Older MRSA carriers had less
knowledge (OR 0.7 per 10 year increase, 95 % CI 0.5 to
1.0, p = 0.049) as well as those participants attaching
more importance to MRSA (OR 0.4, 95 % CI 0.2 to 0.9,
p = 0.034). Interestingly, education level was not associ-
ated with knowledge related to MRSA (Table 4).
About a quarter of the respondents (27.3 %) stated
that no professional healthcare worker has talked to
them about MRSA. The remaining reported more often
talking with hospital staff (physicians or nursing staff )
than with physicians or nurses in the outpatient care ser-
vice (data not shown). Twenty-one percent reported to
attribute no importance to the positive MRSA result,
but 51.0 % were scared of MRSA.
Half of the respondents (49.3 %) reported that their
general state of health was “not so good” or “bad”, and
20.0 % of the participants reported a deterioration of
their quality of life due to MRSA.
One third (30.7 %) responded affirmatively to at least one
question indicating stigmatization, and the aspect the most
frequently reported was self-restriction of social contacts in
order to prevent transmission (17.4 %). Of patients younger
than 65 years (which was retirement age in Germany), 10 %
(4/40) reported occupational problems because of MRSA.
Participants also reported stigmatization in the context of
health care services (Fig. 2).
Only one third (33.3 %) reported that their MRSA status
was evaluated after discharge from hospital. Nearly half of
the respondents (47.3 %) received a decolonization ther-
apy, and of those, 52.1 % (37/71) reported that a control
swab was taken in the outpatient sector (Table 3).
Asked about the application of the recommended
measures in detail, only ten participants (6.7 %) stated
that all listed measures had been applied; the application
of nasal ointment being the most common (64.3 % of all
MRSA carriers) (Fig. 3). According to our data, the pres-
ence of self-reported risk factors for prolonged MRSA
carriage like chronic wounds or urinary catheters did
not influence the application of decolonization therapy
(Chi2 test, p = 0.636).
Discussion
We analyzed knowledge, attitude and practice among
MRSA carriers and physicians in the outpatient sector in
Germany after the introduction of reimbursement for
MRSA related therapy. Physicians displayed heteroge-
neous knowledge and level of activity regarding MRSA
specific aspects. Almost one third of the responding
MRSA carriers stated that no healthcare professional
had ever talked to them about MRSA. Thirty percent
claimed that their quality of life deteriorated due to
Table 3 Characteristics of MRSA carriers
N (%e)
Total 150 (100 %)
Age, n = 146
Median (IQR) in years 71.5 (60–78)
Sex, n = 146
Female 67 (44.7 %)
Education, n = 136
Lowa 83 (55.3 %)
Intermediateb 30 (20.0 %)
Highc 23 (15.3 %)
Living in a long term
care facility, n = 141
Yes 9 (6.0 %)
No 132 (88.0 %)
Need of nursing care
(“Pflegestufe”), n = 144
Yes 50 (33.3 %)
No 94 (62.7 %)
Migration Backgroundd, n = 147
Yes 15 (10.0 %)
No 132 (88.0 %)
Risk factors for MRSA
(multiple selection possible), n = 150
Urinary catheter 9 (6.0 %)
Dialysis 10 (6.7)
Chronic wounds 13 (8.7 %)
Chronic skin disease 12 (8.0 %)
Occupational exposure to lifestock 1 (0.7 %)
No risk factor 116 (77.3 %)
Decontamination therapy applied, n = 132
Yes 71 (47.3 %)
in the hospital 44 (29.3 %)
at home 21 (14.0 %)
in the hospital and at home 29 (19.3 %)
No 61 (40.6 %)
Control swabs for MRSA in the
outpatient sector, n = 144
Yes 50 (33.3 %)
Control swab and decolonization
therapy was applied, n = 132
Yes 37 (24.7 %)
aLow level of school education (<10 years)
bIntermediate level of school education (10–12 years)
cHigh level of school education (12–13 years)
dMigration defined as not being born in Germany or/and mother tongue
not German
e Calculation of proportions includes missing values in the denominator
IQR interquartile range
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MRSA and one third experienced stigmatization due to
MRSA or exerted self-stigmatization.
Similarly,the reduction of social contacts and leisure
activities among MRSA carriers was also reported in a
Swedish study [7] and in our own focus groups, where
participants reported the reduction of social contacts,
e.g., to their grandchildren as a consequence of the
MRSA finding [10]. Such behaviour is generally not rec-
ommended in official guidelines [12]. Nevertheless, some
MRSA carriers seem to overestimate the risk associated
with MRSA for healthy and non-hospitalized individuals.
It might be advisable to proactively address this topic
in patient information leaflets and physician-patient
consultations.
Some participants reported a rejection by health care ser-
vices like a nursing home or a rehabilitation clinic because
of MRSA. Further studies are necessary to investigate to
which extent the medical treatment of the underlying con-
ditions is negatively influenced by a positive MRSA status.
MRSA carriers who sought additional information
about MRSA on the internet or by reading newspapers
could answer more knowledge questions correctly. This
suggests that publicly available information on MRSA is
used by MRSA carriers and has a positive effect on their
knowledge. Hence, the quality and availability of public
information on MRSA is important. Thirty percent of
the respondents claimed that no healthcare professional
had ever talked to them about MRSA. Astonishingly,
some of these also reported the application of a
decolonization therapy. In these cases, either the
decolonization therapy has been applied without a
proper clarification or the responding MRSA carriers did
not remember the education about MRSA. Respondents
gave, however, more inconsistent answers in this area:
only 71 respondents reported at least one decolonization
therapy, whereas 90 reported the application of nasal
ointment. These contradictions also underline the lack
of specific knowledge of the MRSA carriers. Around
30 % of the answers to the knowledge questions were
“don’t know”, which indicates rather substantial deficits
in the knowledge among MRSA carriers. The need for
more information was also a key finding in qualitative
studies from Great Britain and Sweden [6, 7]. Partici-
pants of our qualitative part of the study also reported a
need for more and adequate information [10]. The regu-
lation of the German National Association of Statutory
Health Insurance allows reimbursement for ten minutes
of conversation about MRSA twice during the treatment
process [13]. Taking the complexity of the topic into ac-
count, it seems challenging to give adequate information
in ten minutes, which could in part explain the informa-
tion deficit of the MRSA carriers.
Rather surprisingly, 42 % of the responding physicians
stated that there was not enough information available
on MRSA. Various organizations in Germany (Rob-
ert Koch- Institute, Association of Health Insurance
Doctors etc.) have detailed, freely available information
on MRSA on their websites. In order to raise awareness
of MRSA among physicians in the outpatient sector, it
might not be sufficient to make information available
Fig. 1 Knowledge of MRSA carriers
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through internet but it might be essential to additionally
spread information proactively through medical journals
or leaflets.
Only one third (33.3 %) of the MRSA carriers in our
study reported to have received control swabs in the
outpatient sector. This can be put in the context to the
results of the survey among physicians, which showed a
huge heterogeneity in their activity towards MRSA.
Correspondingly, only half of the MRSA carriers re-
ported a decolonization therapy, even though it was rec-
ommended for all patients except those with underlying
conditions like, e.g., dialysis. However, the application of
a decolonization therapy was not associated with the
presence of these conditions among patients in our
study population. So why did only half of the patients
get a decolonization therapy? One reason could be that
Table 4 Variables associated with MRSA carriers’ knowledge related to MRSA










n (%)a n (%)a
82 (54.7 %) 68 (45.3)





Median (IQR) in years 74 (65–79.5) 66 (53–77) 0.011
Sex
Female 35 (43.8 %) 32 (48.5 %) 0.568 1.2 (0.6–2.3)
Male 45 (56.3 %) 34 (51.5 %) 1
Education
Low 53 (72.6 %) 30 (47.6 %) 0.011 1
Intermediate 12 (16.4 %) 18 (28.6 %) 2.6 (1.1–6.2)
High 8 (11.0 %) 15 (23.8 %) 3.3 (1.3–8.7)
Migration Background
Yes 11 (13.9 %) 4 (5.9 %) 0.108 0.4 (0.1–1.3)
No 68 (86.1 %) 64 (94.1 %) 1
Source of Information
Internet
Yes 9 (11.0 %) 25 (36.8 %) <0.0001 5.4 (2.0–11.0) 5.0 (1.8–14.0) 0.002
No 73 (89.0 %) 43 (63.2 %) 1 1
Newspaper
Yes 8 (9.8 %) 14 (20.6 %) 0.015 2.4 (0.9–6.1) 5.4 (1.6–17.5) 0.005
No 74 (90.2 %) 54 (79.4 %) 1 1
Television/Radio
Yes 7 (8.5 %) 13 (19.1 %) 0.058 2.5 (0.9–6.8)
No 75 (91.5 %) 55 (80.9 %) 1
MRSA discussed with healthcare professional
At least one 54 (65.9 %) 55 (80.9 %) 0.040 2.2 (1.0–4.7)
None at all 28 (34.2) 13 (19.1 %) 1
Attitude: Importance of MRSA
High 51 (68.0 %) 35 (51.5 %) 0.004 0.5 (0.3–1.0) 0.4 (0.2–0.9) 0.034
Low 24 (32.0 %) 33 (48.5 %) 1 1
Attitude: Scared of MRSA
Scared of MRSA 46 (59.0 %) 29 (42.7 %) 0.049 0.5 (0.3–1.0)
Not scared of MRSA 32 (41.0 %) 39 (57.4 %) 1
a Differences to total N due to missing values
b Logistic regression with forward selection of variables; mutually adjusted for all variables with reported ORs in the table
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MRSA diagnosis is not always reported in the discharge
letter. According to a recent report of the European Ob-
servatory on Health Systems and Policies “communication
between GPs and hospitals is problematic” in Germany
[14] as well as in some other European countries [15]. Ac-
cording to this report, in Spain, e.g., the cooperation be-
tween sectors is standard practice and has been facilitated
by shared electronic clinical record and IT systems [14].
One possibility to overcome the sectoral gap might be the
establishment of infection control teams taking care of the
diagnosed MRSA carriers beyond the discharge from
hospitals. Furthermore, it might be difficult for the physi-
cians to develop routines with regard to MRSA due to the
small number of cases. Kock et al. [2] estimated 132,000
MRSA cases in German hospitals per year; distributing
them on the 37,353 general practitioners (GPs) in
Germany in 2013 [16], one GP would see on average 3.5
MRSA carriers per year. This is quite comparable to the
median of 5 MRSA carriers that were reported by the
physicians in our data. This small number might result in a
vicious circle: physicians attach little importance to MRSA,
do not seek information about MRSA, and underestimate
Fig. 2 Stigmatization related to MRSA
Fig. 3 Decolonization therapy: Application of single measures
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the number of patients at risk for MRSA, therefore apply
screening measures too seldom, and consequently have low
numbers of MRSA carriers among their patients.
Only few respondents reported that all recommeded
measures (disinfectant washing etc.) were applied. One
reason could be that only the costs for nasal ointment
are covered by the health insurances, the carriers having
to bear the rest of the costs themselves. The other rea-
son could be, that physicians do not believe all the mea-
sures to be necessary: only one third (36 %) agreed fully
with the general recommendations. The poor adherence
and low agreement with the recommendations might be
due to a lack of studies showing the effectiveness of the
various recommended measures as was highlighted be-
fore by Faetkenheuer et al. [17]; however, we have no
insight from our study to which aspects of the recom-
mendations exactly the physicians do not agree and why.
Studies exploring the effectiveness of (outpatient)
decolonization therapy and the effectiveness of its single
components could improve the acceptance of these
measures.
Limitations
The study was carried out in two regions in Germany and
might not reflect the situation in all of Germany. While
MRSA status was based on medical records, all further
data on decolonization therapy and medical conditions
were self-reported by MRSA carriers. Misclassification
concerning application of control swabs, decolonization
therapy or medical conditions e.g., due to recall problems
cannot be excluded. Only 9.5 % of the physicians returned
our questionnaire. Thus, our analysis is prone to selection
bias, and the results have to be interpreted with caution.
Knowledge, attitude, and activity might be higher among
participants than among the whole source population.
However, 22 % of responding physicians indicated that
MRSA was not important in their daily work, and 10 %
stated, that they had had no MRSA carriers among their
patients in the last 12 months. Thus, we may assume that
non-responders are not interested in taking part in studies
in general and they are not specifically uninterested in
MRSA. This may lead to less bias in our findings.
The response proportion of the MRSA carriers was
16.5 %. It can be assumed that in this population non-
responders might be frailer than respondents, and thus
face different problems concerning MRSA. Unfortu-
nately, we are not able to show this. To approach these
hard to reach populations further research with a differ-
ent approach, e.g., interviews, would be necessary.
Conclusion
Relevance attributed to MRSA and experience with ap-
plication of MRSA specific therapy were highly hetero-
geneous among physicians in the outpatient sector.
Raising the awareness towards MRSA in the outpatient
healthcare sector appears imperative to improve treat-
ment of MRSA carriers. Additionally, health care profes-
sionals should be aware of possible stigmatization and of
the fact that lack of adequate information can result in
inappropriate deprivation of social contacts. MRSA car-
riers need more and adequate information about MRSA.
This information should include the fact that MRSA is
no threat to healthy people.
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